Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers By Ogkologos - February 19, 2025 652 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR FDA Approves Blinatumomab as Consolidation for CD19-positive Philadelphia Chromosome-negative B-Cell Precursor... August 6, 2024 Efficacy of Sintilimab in the Adjuvant Treatment for Patients with Resected,... January 26, 2024 EMA Recommends Granting a Marketing Authorisation for Lutetium (177lu) Chloride August 4, 2022 Mom Births Stillborn Baby But Never Anticipated Nurse’s Remark She Will... March 15, 2019 Load more HOT NEWS FDA Grants Accelerated Approval to Daratumumab Plus Hyaluronidase for Newly Diagnosed... Adding Tucatinib to T-DM1 Improves PFS in Previously Treated HER2-positive Advanced... FDA Grants Accelerated Approval to Adagrasib for KRAS G12C-Mutated NSCLC Cancer waiting times: Latest updates and analysis
